Livzon Pharma Details New Board and Committee Line-up; Zhu Baoguo Continues as Chairman

Bulletin Express03-24

Zhuhai-based Livzon Pharmaceutical Group Inc. (Livzon Pharma) released an update on 24 March 2026 outlining the composition of its Board of Directors and five specialised board committees.

The Board now consists of nine members: • Executive Director – Tang Yanggang (Vice Chairman) • Non-executive Directors – Zhu Baoguo (Chairman), Lin Nanqi, Qiu Qingfeng • Employee Representative Director – Ran Yongmei • Independent Non-executive Directors – Bai Hua, Luo Huiyuan, Cui Lijie, Wang Zhiyao

Committee structure and key roles 1. Five committees are in place: Audit; Remuneration and Assessment; Nomination; Strategy; and Environmental, Social and Governance (ESG). 2. Chairmanships are distributed among four directors: – Zhu Baoguo heads two committees. – Bai Hua, Luo Huiyuan and Cui Lijie each chair one committee. 3. Executive Director Tang Yanggang serves as a member of four committees, providing operational representation across most governance functions. 4. All independent non-executive directors participate in at least one committee, in line with corporate governance best practices.

The updated structure is designed to strengthen oversight in key areas—financial reporting, remuneration, strategic planning and ESG—while maintaining a balanced mix of executive, non-executive and independent perspectives on the Board.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1113419898?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-24 21:23","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1113419898","market":"us","top_or_hot":-1,"title":"Livzon Pharma Details New Board and Committee Line-up; Zhu Baoguo Continues as Chairman","media":"Bulletin Express","content":"<p>Zhuhai-based Livzon Pharmaceutical Group Inc. (Livzon Pharma) released an update on 24 March 2026 outlining the composition of its Board of Directors and five specialised board committees.</p>\n<p>The Board now consists of nine members:  \n• Executive Director – Tang Yanggang (Vice Chairman)  \n• Non-executive Directors – Zhu Baoguo (Chairman), Lin Nanqi, Qiu Qingfeng  \n• Employee Representative Director – Ran Yongmei  \n• Independent Non-executive Directors – Bai Hua, Luo Huiyuan, Cui Lijie, Wang Zhiyao</p>\n<p>Committee structure and key roles  \n1. Five committees are in place: Audit; Remuneration and Assessment; Nomination; Strategy; and Environmental, Social and Governance (ESG).  \n2. Chairmanships are distributed among four directors:  \n   – Zhu Baoguo heads two committees.  \n   – Bai Hua, Luo Huiyuan and Cui Lijie each chair one committee.  \n3. Executive Director Tang Yanggang serves as a member of four committees, providing operational representation across most governance functions.  \n4. All independent non-executive directors participate in at least one committee, in line with corporate governance best practices.</p>\n<p>The updated structure is designed to strengthen oversight in key areas—financial reporting, remuneration, strategic planning and ESG—while maintaining a balanced mix of executive, non-executive and independent perspectives on the Board.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Livzon Pharma Details New Board and Committee Line-up; Zhu Baoguo Continues as Chairman</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLivzon Pharma Details New Board and Committee Line-up; Zhu Baoguo Continues as Chairman\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-24 21:23</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Zhuhai-based Livzon Pharmaceutical Group Inc. (Livzon Pharma) released an update on 24 March 2026 outlining the composition of its Board of Directors and five specialised board committees.</p>\n<p>The Board now consists of nine members:  \n• Executive Director – Tang Yanggang (Vice Chairman)  \n• Non-executive Directors – Zhu Baoguo (Chairman), Lin Nanqi, Qiu Qingfeng  \n• Employee Representative Director – Ran Yongmei  \n• Independent Non-executive Directors – Bai Hua, Luo Huiyuan, Cui Lijie, Wang Zhiyao</p>\n<p>Committee structure and key roles  \n1. Five committees are in place: Audit; Remuneration and Assessment; Nomination; Strategy; and Environmental, Social and Governance (ESG).  \n2. Chairmanships are distributed among four directors:  \n   – Zhu Baoguo heads two committees.  \n   – Bai Hua, Luo Huiyuan and Cui Lijie each chair one committee.  \n3. Executive Director Tang Yanggang serves as a member of four committees, providing operational representation across most governance functions.  \n4. All independent non-executive directors participate in at least one committee, in line with corporate governance best practices.</p>\n<p>The updated structure is designed to strengthen oversight in key areas—financial reporting, remuneration, strategic planning and ESG—while maintaining a balanced mix of executive, non-executive and independent perspectives on the Board.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01513","symbol_name":"丽珠医药","start_time":0,"source_url":"","article_id":"1113419898","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1113419898","pubTimestamp":1774358599,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Zhuhai-based Livzon Pharmaceutical Group Inc. (Livzon Pharma) released an update on 24 March 2026 outlining the composition of its Board of Directors and five specialised board committees. The Board...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01513":"丽珠医药"},"translate_title":"丽珠医药详细介绍新董事会和委员会阵容；朱保国继续担任董事长","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01513":1},"content_text":"Zhuhai-based Livzon Pharmaceutical Group Inc. (Livzon Pharma) released an update on 24 March 2026 outlining the composition of its Board of Directors and five specialised board committees.\nThe Board now consists of nine members:  \n• Executive Director – Tang Yanggang (Vice Chairman)  \n• Non-executive Directors – Zhu Baoguo (Chairman), Lin Nanqi, Qiu Qingfeng  \n• Employee Representative Director – Ran Yongmei  \n• Independent Non-executive Directors – Bai Hua, Luo Huiyuan, Cui Lijie, Wang Zhiyao\nCommittee structure and key roles  \n1. Five committees are in place: Audit; Remuneration and Assessment; Nomination; Strategy; and Environmental, Social and Governance (ESG).  \n2. Chairmanships are distributed among four directors:  \n   – Zhu Baoguo heads two committees.  \n   – Bai Hua, Luo Huiyuan and Cui Lijie each chair one committee.  \n3. Executive Director Tang Yanggang serves as a member of four committees, providing operational representation across most governance functions.  \n4. All independent non-executive directors participate in at least one committee, in line with corporate governance best practices.\nThe updated structure is designed to strengthen oversight in key areas—financial reporting, remuneration, strategic planning and ESG—while maintaining a balanced mix of executive, non-executive and independent perspectives on the Board.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"executive,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.39.0","shortVersion":"4.39.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1113419898","isCrawlerRequest":true}